<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">34973</article-id><article-id pub-id-type="doi">10.26442/00403660.2020.06.000545</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Case reports</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Клинические наблюдения</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Kidney health for everyone everywhere – from prevention to detection and equitable access to care</article-title><trans-title-group xml:lang="ru"><trans-title>Здоровые почки всем и везде: от профилактики и выявления до равного доступа к медицинской помощи</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kam-Tao Li</surname><given-names>Philip</given-names></name><name xml:lang="ru"><surname>Кам-Тао Ли</surname><given-names>Филипп</given-names></name></name-alternatives><address><country country="CN">China</country></address><bio xml:lang="en"><p>Carol &amp; Richard Yu PD Research Centre, Prince of Wales Hospital, Department of Medicine and Therapeutics</p></bio><bio xml:lang="ru"><p>MD, FRCP, FACP; Исследовательский центр им. Кэрол и Ричарда Ю, Больница принца Уэльского, отдел медицины и терапии</p></bio><email>philipli@cuhk.edu.hk</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Garcia-Garcia</surname><given-names>G.</given-names></name><name xml:lang="ru"><surname>Гарсия-Гарсия</surname><given-names>Г.</given-names></name></name-alternatives><address><country country="MX">Mexico</country></address><bio xml:lang="en"><p>Hospital Civil de Guadalajara Fray Antonio Alcalde, Nephrology Service</p></bio><bio xml:lang="ru"><p>Гвадалахарский гражданский госпиталь им. Фрая Антонио Алькальде, отделение нефрологии</p></bio><email>kkz@uci.edu</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lui</surname><given-names>S.-F.</given-names></name><name xml:lang="ru"><surname>Луи</surname><given-names>С.-Ф.</given-names></name></name-alternatives><address><country country="CN">China</country></address><bio xml:lang="en"><p>Jockey Club School of Public Health and Primary Care, Division of Health System, Policy and Management</p></bio><bio xml:lang="ru"><p>Школа общественного здравоохранения и первичной медико-санитарной помощи «Жокей-клуб», отдел организации управления здравоохранением</p></bio><email>kkz@uci.edu</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Andreoli</surname><given-names>S.</given-names></name><name xml:lang="ru"><surname>Андреоли</surname><given-names>Ш.</given-names></name></name-alternatives><address><country country="US">United States</country></address><bio xml:lang="en"><p>James Whitcomb Riley Hospital for Children</p></bio><bio xml:lang="ru"><p>Больница им. Джейма Уиткомба Райли для детей</p></bio><email>kkz@uci.edu</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Wing-Shing Fung</surname><given-names>W.</given-names></name><name xml:lang="ru"><surname>Винг-Шинг Фунг</surname><given-names>У.</given-names></name></name-alternatives><address><country country="CN">China</country></address><bio xml:lang="en"><p>Carol &amp; Richard Yu PD Research Centre, Prince of Wales Hospital, Department of Medicine and Therapeutics</p></bio><bio xml:lang="ru"><p>Исследовательский центр им. Кэрол и Ричарда Ю, Больница принца Уэльского, отдел медицины и терапии</p></bio><email>kkz@uci.edu</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Hradsky</surname><given-names>A.</given-names></name><name xml:lang="ru"><surname>Градски</surname><given-names>А.</given-names></name></name-alternatives><address><country country="BE">Belgium</country></address><email>kkz@uci.edu</email><xref ref-type="aff" rid="aff5"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kumaraswami</surname><given-names>L.</given-names></name><name xml:lang="ru"><surname>Кумарасвами</surname><given-names>Л.</given-names></name></name-alternatives><address><country country="IN">India</country></address><email>kkz@uci.edu</email><xref ref-type="aff" rid="aff6"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Liakopoulos</surname><given-names>V.</given-names></name><name xml:lang="ru"><surname>Лиакопулос</surname><given-names>В.</given-names></name></name-alternatives><address><country country="GR">Greece</country></address><bio xml:lang="en"><p>Division of Nephrology and Hypertension, 1st Department of Internal Medicine</p></bio><bio xml:lang="ru"><p>отдел нефрологии и артериальной гипертензии, 1-я кафедра терапии и внутренних болезней</p></bio><email>kkz@uci.edu</email><xref ref-type="aff" rid="aff7"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rakhimova</surname><given-names>Z.</given-names></name><name xml:lang="ru"><surname>Рахимова</surname><given-names>З.</given-names></name></name-alternatives><address><country country="BE">Belgium</country></address><email>kkz@uci.edu</email><xref ref-type="aff" rid="aff5"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Saadi</surname><given-names>G.</given-names></name><name xml:lang="ru"><surname>Саади</surname><given-names>Г.</given-names></name></name-alternatives><address><country country="EG">Egypt</country></address><bio xml:lang="en"><p>Nephrology Unit, Department of Internal Medicine, Faculty of Medicine</p></bio><bio xml:lang="ru"><p>отдел внутренних болезней, медицинский факультет</p></bio><email>kkz@uci.edu</email><xref ref-type="aff" rid="aff8"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Strani</surname><given-names>L.</given-names></name><name xml:lang="ru"><surname>Страни</surname><given-names>Л.</given-names></name></name-alternatives><address><country country="BE">Belgium</country></address><email>kkz@uci.edu</email><xref ref-type="aff" rid="aff5"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ulasi</surname><given-names>I.</given-names></name><name xml:lang="ru"><surname>Уласи</surname><given-names>И.</given-names></name></name-alternatives><address><country country="NG">Nigeria</country></address><bio xml:lang="en"><p>Renal Unit, Department of Medicine, College of Medicine</p></bio><bio xml:lang="ru"><p>Медицинский колледж, медицинский факультет, отделение нефрологии</p></bio><email>kkz@uci.edu</email><xref ref-type="aff" rid="aff9"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kalantar-Zadeh</surname><given-names>K.</given-names></name><name xml:lang="ru"><surname>Калантар-Заде</surname><given-names>К.</given-names></name></name-alternatives><address><country country="US">United States</country></address><bio xml:lang="en"><p>Division of Nephrology and Hypertension and Kidney Transplantation</p> <p> </p><p> </p> </bio><bio xml:lang="ru"><p>отдел нефрологии, артериальной гипертензии и трансплантации почки</p></bio><email>kkz@uci.edu</email><xref ref-type="aff" rid="aff10"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Chinese University of Hong Kong</institution></aff><aff><institution xml:lang="ru">Китайский университет Гонконга</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">University of Guadalajara Health Sciences Center</institution></aff><aff><institution xml:lang="ru">Научный центр здоровья Университета Гвадалахары</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">The Chinese University of Hong Kong</institution></aff><aff><institution xml:lang="ru">Китайский университет Гонконга</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Indiana University School of Medicine</institution></aff><aff><institution xml:lang="ru">Медицинская школа Университета Индианы</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">World Kidney Day Office</institution></aff><aff><institution xml:lang="ru">Головной офис инициативы «Всемирный день почки»</institution></aff></aff-alternatives><aff-alternatives id="aff6"><aff><institution xml:lang="en">Tanker Foundation</institution></aff><aff><institution xml:lang="ru">Фонд Танкер</institution></aff></aff-alternatives><aff-alternatives id="aff7"><aff><institution xml:lang="en">AHEPA Hospital, Aristotle University of Thessaloniki</institution></aff><aff><institution xml:lang="ru">Госпиталь Aмериканской эллинской образовательной ассоциации, Университет им. Аристотеля в Салониках</institution></aff></aff-alternatives><aff-alternatives id="aff8"><aff><institution xml:lang="en">Cairo University</institution></aff><aff><institution xml:lang="ru">Каирский университет</institution></aff></aff-alternatives><aff-alternatives id="aff9"><aff><institution xml:lang="en">University of Nigeria</institution></aff><aff><institution xml:lang="ru">Университет Нигерии</institution></aff></aff-alternatives><aff-alternatives id="aff10"><aff><institution xml:lang="en">University of California Irvine School of Medicine</institution></aff><aff><institution xml:lang="ru">Медицинская школа г. Ирвайн, Калифорнийский университет</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-07-09" publication-format="electronic"><day>09</day><month>07</month><year>2020</year></pub-date><volume>92</volume><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>4</fpage><lpage>14</lpage><history><date date-type="received" iso-8601-date="2020-07-07"><day>07</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/34973">https://ter-arkhiv.ru/0040-3660/article/view/34973</self-uri><abstract xml:lang="en"><p>The global burden of chronic kidney disease (CKD) is rapidly increasing with a projection of becoming the 5th most common cause of years of life lost globally by 2040. Aggravatingly, CKD is a major cause of catastrophic health expenditure. The costs of dialysis and transplantation consume up to 3% of the annual healthcare budget in high-income countries. Crucially, however, the onset and progression of CKD is often preventable. In 2020, the World Kidney Day campaign highlights the importance of preventive interventions – be it primary, secondary or tertiary. This complementing article focuses on outlining and analyzing measures that can beimplemented in every country to promote and advance CKD prevention. Primary prevention of kidney disease should focus on the modification of risk factors and addressing structural abnormalities of the kidney and urinary tracts, as well as exposure to environmental risk factors and nephrotoxins. In persons with pre-existing kidney disease, secondary prevention, including blood pressure optimization and glycemic control, should be the main goal of education and clinical interventions. In patients with advanced CKD, management of co-morbidities such as uremia and cardiovascular disease is a highly recommended preventative intervention to avoid or delay dialysis or kidney transplantation. Political efforts are needed to proliferate the preventive approach. While national policies and strategies for non-communicable diseases might be present in a country, specific policies directed toward education and awareness about CKD screening, management and treatment are often lacking. Hence, there is an urgent need to increase the awareness of the importance of preventive measures throughout populations, professionals and policy makers.</p></abstract><trans-abstract xml:lang="ru"><p>Глобальное бремя хронической болезни почек (ХБП) стремительно увеличивается. Так, согласно прогнозам, к 2040 г. ХБП окажется на 5-м месте среди наиболее частых причин сокращения продолжительности жизни во всем мире. Более того, ХБП является основной причиной катастрофических расходов на здравоохранение. В странах с высоким уровнем дохода расходы на диализ и трансплантацию составляют до 3% от ежегодного бюджета здравоохранения. В связи с этим особенно важно, что развитие и прогрессирование ХБП во многих случаях можно предотвратить. В 2020 г. кампания «Всемирный день почки» посвящена в первую очередь мероприятиям по первичной, вторичной и третичной профилактике ХБП. В данной статье представлены описание и анализ мер, которые могут быть внедрены в каждой стране с целью пропаганды и дальнейшего развития профилактики ХБП. Первичная профилактика заболеваний почек должна быть направлена на модификацию факторов риска и устранение структурных повреждений почек и мочевыводящих путей, а также ограничение воздействия факторов риска окружающей среды и нефротоксических веществ. У лиц, уже страдающих заболеваниями почек, вторичная профилактика (включая оптимизацию артериального давления и контроль гликемии) должна быть основной целью как обучения, так и клинических вмешательств. У пациентов с далеко зашедшими стадиями ХБП настоятельно рекомендуются превентивные меры, позволяющие предотвратить или отсрочить потребность в диализе или трансплантации почки, а именно лечение уремии и сопутствующих состояний, таких как сердечно-сосудистые заболевания. Для реализации профилактического подхода необходимо принятие мер на государственном уровне. Несмотря на то, что в той или иной стране могут существовать национальная политика и стратегия по профилактике неинфекционных заболеваний в целом, конкретные меры, направленные на повышение осведомленности и настороженности в отношении диагностики, ведения и лечения ХБП, часто отсутствуют. В связи с этим необходимо повышение информированности населения, медицинских работников и политиков о важной роли профилактических мероприятий.</p></trans-abstract><kwd-group xml:lang="en"><kwd>кidney diseases</kwd><kwd>prevention</kwd><kwd>detection</kwd><kwd>awareness</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>заболевания почек</kwd><kwd>профилактика</kwd><kwd>выявление</kwd><kwd>осведомленность</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>International Society of Nephrology. 2019 United Nations High Level Meeting on UHC: Moving Together to Build Kidney Health worldwide. Retrieved 20 July 2019. https://www.theisn.org/images/ Advocacy_4_pager_2019_Final_WEB_pagebypage.pdf</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392(10159):2052-90. doi: 10.1016/S0140-6736(18)31694-5</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Essue BM, Laba TL, Knaul F, et al. Economic burden of chronic ill health and injuries for households in low- and middle-income countries. In: Jamison DT, Gelband H, Horton S, et al., eds. Disease Control Priorities Improving Health and Reducing Poverty. 3 ed. Washington, DC: World Bank; 2018:121-43.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Vanholder R, Annemans L, Brown E, et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol. 2017;13(7):393-409. doi: 10.1038/nrneph.2017.63</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Luyckx VA, Tuttle KR, Garcia-Garcia G, et al. Reducing major risk factors for chronic kidney disease. Kidney Int Suppl. 2017;7(2):71-87. doi: 10.1016/j.kisu.2017.07.003</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96(6):414-22D. doi: 10.2471/BLT.17.206441</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Tonelli M, Muntner P, Lloyd A, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012;380(9844):807-14. doi: 10.1016/S0140-6736(12)60572-8</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Kalantar-Zadeh K, Fouque D. Nutritional Management of Chronic Kidney Disease. N Engl J Med. 2017;377(18):1765-76. doi: 10.1056/ NEJMra1700312</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>United Nations General Assembly. Political declaration of the third high-level meeting of theGeneral Assembly on the prevention and control ofnon-communicable diseases (2018). Retrieved from https://www.un.org/ga/ search/view_doc.asp?symbol=A/73/L.2&amp;Lang=E</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Lopez AD, et al. Remembering the forgotten non-communicable diseases. BMC Medicines. 2014;12(1):200. doi: 10.1186/s12916-014-0200-8</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>(CDC) Center for Disease Control and Prevention. «Picture of America» (www.cdc.gov/pictureofamerica). At a Glance – Executive Summary. 2017;2019.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Levey AS, Schoolwerth AC, Burrows NR, et al., Centers for Disease Control and Prevention Expert Panel. Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. Am J Kidney Dis. 2009;53(3):522-35. doi: 10.1053/j.ajkd.2008.11.019</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2019;73(3S1):A7-A8. doi: 10.1053/j.ajkd. 2019.01.001</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Kovesdy CP, Furth SL, Zoccali C, World Kidney Day Steering Committee. Obesity and Kidney Disease: Hidden Consequences of the Epidemic. J Ren Nutr. 2017;27(2):75-7. doi: 10.4102/phcfm.v9i1.1435</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Tantisattamo E, Dafoe DC, Reddy UG, et al. Current Management of Acquired Solitary Kidney. Kidney Int Reports. 2019;4(9):1205-18. doi: 10.1016/j.ekir.2019.07.001</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017;389(10075):1238-52. doi: 10.1016/S0140-6736(16)32064-5</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Koppe L, Fouque D. The Role for Protein Restriction in Addition to Renin-Angiotensin-Aldosterone System Inhibitors in the Management of CKD. Am J Kidney Dis. 2019;73(2):248-57. doi: 10.1053/j.ajkd.2018.06.016</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Rifkin DE, Coca SG, Kalantar-Zadeh K. Does AKI truly lead to CKD? J Am Soc Nephrol. 2012;23(6):979-84. doi: 10.1681/ASN.2011121185</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Torres VE, Chapman AB, Devuyst O, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367(25):2407-18. doi: 10.1056/NEJMoa1205511</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Verhave JC, Troyanov S, Mongeau F, et al. Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care. Clin J Am Soc Nephrol. 2014;9:7139. doi: 10.2215/CJN.06550613</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Chow KM, Szeto CC, Kwan B, et al. Public lacks knowledge on chronic kidney disease: Telephone survey. Hong Kong Med J. 2014;20:139-44.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Ene-Iordache B, Perico N, Bikbov B, et al. Chronic kidney diseaseand cardiovascular risk in six regions of the world (ISN-KDDC): Across-sectional study. Lancet Glob Health. 2016;4:e307-19.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Li PKT, Weening JJ, Dirks J, et al. A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease. Kidney Int Suppl. 2005;(94):s2-7. doi: 10.1111/j.1523-1755.2005.09401.x</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: A position statement from the National Kidney Foundation. Am J Kidney Dis. 2007;50:169-80. doi: 10.1053/j.ajkd.2007.06.013</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: Approaches and initiatives – aposition statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72:247-59. doi: 10.1038/sj.ki.5002343</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Crowe E, Halpin D, Stevens P; Guideline Development Group. Early identification and management of chronic kidney disease: summary of NICE guidance. BMJ. 2008;337:a1530. doi: 10.1136/bmj.a1530</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Li PKT, Chow KM, Matsuo S, et al. Asian Chronic Kidney Disease (CKD) Best Practice Recommendations – Positional Statements for Early Detection of CKD from Asian Forum for CKD Initiatives (AFCKDI). Nephrology. 2011;16(7):633-41. doi: 10.1111/j.1440-1797.2011.01503.x</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Fink HA, Ishani A, Taylor BC, et al.: Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: A systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2012;156:570-81. doi: 10.7326/0003-4819-156-8-201204170-00008</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Li PKT, Ng JK, Cheng YL, et al. Relatives In Silent Kidney disease Screening study (RISKS): a Chinese cohort study. Nephrology. 2017;22(Suppl. 4):35-42. doi: 10.1111/nep.13148</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Samal L, Linder JA. The primary care perspective on routine urine dipstick screening to identify patients with albuminuria. Clin J Am Soc Nephrol. 2013 Jan;8(1):131-5. doi: 10.2215/CJN.12681211</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>George C, Mogueo A, Okpechi I, et al. Chronic kidney disease in low-income to middle-income countries: the case for increased screening. BMJ Glob Health. 2017;2(2):e000256. doi: 10.1136/bmjgh-2016-000256</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Gonzalez-Quiroz M, Nitsch D, Hamilton S, et al.; DEGREE Study Steering Committee. Rationale and population-based prospective cohort protocol for the disadvantaged populations at risk of decline in eGFR (CO-DEGREE). BMJ Open. 2019;9:e031169. doi: 10.1136/bmjopen-2019-031169</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Boulware LE, Jaar BG, Tarver-Carr ME, et al. Screening for proteinuria in US adults: A cost-effectiveness analysis. JAMA. 2003;290:3101-14. doi: 10.1001/jama.290.23.3101</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Go DS, Kim SH, Park J, et al. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea. Nephrology. 2019;24(1):56-64. doi: 10.1111/nep.13203</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Komenda P, Ferguson TW, Macdonald K, et al. Cost-effectiveness of primary screening for CKD: A systematic review. Am J Kidney Dis. 2014;63:789-97. doi: 10.1053/j.ajkd.2013.12.012</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology. 2010;15(Suppl. 2):3-9. doi: 10.1111/j.1440-1797.2010.01304.x</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Almaguer M, Herrera R, Alfonso J, et al. Primary health care strategies for the prevention of end-stage renal disease in Cuba. Kidney Int Suppl. 2005;97:S4-10. doi: 10.1111/j.1523-1755.2005.09701.x</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Alamaguer-Lopez M, Herrera-Valdez R, Diaz J, Rodriguez O. Integration of chronic kidney disease prevention into noncommunicable disease programs in Cuba. In G. Garcia-Garcia, L.Y. Agodoa, &amp; K.C. Norris (Eds.), Chronic Kidney Disease in Disadvantaged Populations 2017 (p. 357-65). London: Elsevier Inc.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>U.S. Department of Health and Human Services. Advancing American Kidney Health, 2019 accessed Sept 26, 2019. https://aspe.hhs.gov/pdf-report/advancing-american-kidney-health</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>U.S. Department of Health and Human Services. The Special Diabetes Program for Indians. Estimates of Medicare savings, 2019. Accessed Sept 26, 2019. https://aspe.hhs.gov/pdf-report/special-diabetes-program-indians-estimates-medicare-savings</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Bello AK, Nwankwo E, El Nahas AM. Prevention of chronic kidney disease: a global challenge. Kidney Int Suppl. 2005;98:S11-17. doi: 10.1111/j.1523-1755.2005.09802.x</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet. 2010;375(9722):1296-309.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Cortés-Sanabria L, Cabrera-Pivaral CE, Cueto-Manzano AM, et al. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial. Am J Kidney Dis. 2008;51(5):777-88. doi: 10.1053/j.ajkd.2007.12.039</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Martínez-Ramírez HR, Jalomo-Martínez B, Cortés-SanabriaL, et al. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist. Am J Kidney Dis. 2006;47(1):78-87. doi: 10.1053/j.ajkd.2005.09.015</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Cueto-Manzano AM, Martínez-Ramírez HR, Cortes-Sanabria L, Rojas-Campos E. CKD screening and prevention strategies in disadvantaged populations. The role of primary health care professionals. In G. Garcia-Garcia, L.Y. Agodoa, &amp; K.C. Norrris (Eds.), Chronic Kidney Disease in Disadvantaged Populations. 2017 (p. 329-35). London: Elsevier, Inc.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Tapia-Conyer R, Gallardo-Rincon H, Betancourt-Cravioto M. Chronic kidney disease in disadvantaged populations: Online educational programs for NCD prevention and treatment. In G. Garcia-Garcia, L.Y. Agodoa, &amp; K.C. Norris (Eds.), Chronic Kidney Disease in Disadvantaged Populations. 2017 (p. 337-45). London: Elsevier, Inc.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Bello AK, Levin A, Manns BJ, et al. Effective CKD care in European countries: challenges and opportunities for health policy. Am J Kidney Dis. 2015;65(1):15-25. doi: 10.1053/j.ajkd.2014.07.033</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Sharif MU, Elsayed ME, Stack AG. The global nephrology workforce: emerging threats and potential solutions! Clin Kidney J. 2016;9(1):11-22. doi: 10.1093/ckj/sfv111</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Naicker S, Eastwood JB, Plange-Rhule J, Tutt RC. Shortage of healthcare workers in sub-Saharan Africa: a nephrological perspective. Clin Nephrol. 2010;74(Suppl. 1):S129-33.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Cusumano AM, Rosa-Diez GJ, Gonzalez-Bedat MC. Latin American Dialysis and Transplant Registry: Experience and contributions to end-stage renal disease epidemiology. World J Nephrol. 2016;5(5):389-97.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Feehally J, Brusselmans A, Finkelstein FO, et al. Improving global health: measuring the success of capacity building outreach programs: a view from the International Society of Nephrology. Kidney Int Suppl. 2016;6(2):42-51. doi: 10.1016/j.kisu.2016.09.002</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Harris DC, Dupuis S, Couser WG, Feehally J. Training nephrologists from developing countries: does it have a positive impact? Kidney Int Suppl. 2012;2(3):275-8. doi: 10.1038/kisup.2012.32</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Tisher CC, Bastl CP, Bistrian BR, et al. Morbidity and mortality of renal dialysis: an NIH consensus conference statement. Consensus Development Conference Panel. Ann Intern Med. 1994;121(1):62-70.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Garcia-Garcia G, Martinez-Castellanos Y, Renoirte-Lopez K, et al. Multidisciplinary care for poor patients with chronic kidney disease in Mexico. Kidney Int Suppl. 2013;3(2):178-83. doi: 10.1038/kisup.2013.9</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Stanifer JW, Von Isenburg M, Chertow GM, Anand S. Chronic kidney disease care models in low- and middle-income countries: a systematic review. BMJ Glob Health. 2018;3(2):e000728. doi: 10.1136/bmjgh-2018-000728</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Narva AS, Norton JM, Boulware LE. Educating Patients about CKD: The Path to Self-Management and Patient-Centered Care. Clin J Am Soc Nephrol. 2016;11(4):694-703. doi: 10.2215/CJN.07680715</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Schatell D. Web-based kidney education: supporting patient self-management. Semin Dial. 2013;26(2):154-8. doi: 10.1111/sdi.12057</mixed-citation></ref></ref-list></back></article>
